A Compassionate and Visionary Healthcare Architect– Dheeraj Jain: Redefining Fertility Care in India
In the high-pressure world of venture capital and clinical diagnostics, where billions of dollars often chase the next digital fad, Dheeraj Jain looks for something far more permanent: the pulse of a healthy nation. As the Founder of Redcliffe Labs, he has, together with his Partner Aditya Kandoi, steered their venture into becoming the fastest-growing but also third-largest consumer diagnostics company in India in just five years, securing over $120 million from global institutional funds. But when it comes to true success, Redcliffe found it in the nearly $350 million saved by the Indian families through preventive healthcare. “The real victory in business is preventing a crisis before it ever begins,” he believes.
Dheeraj is also an ecosystem builder who creates life protection systems through every stage of life. As the Founder and Group MD of Moon Cares (MMG Group)—alongside Sanjeev Agrawal and Anant Agrawal —that owns 100% of Crysta IVF, the fastest-growing chain of fertility hospitals in India, he has given hope to many families that thought their dreams were never going to come true. Dheeraj has had a vast amount of influence in the areas of PeeSafe’s sanitation inventions, as well as specializing in the area of children’s neuro-healthcare through Continua Kids. By the current times, he has earned accolades as a visionary who identifies the human story behind the numbers. He constantly seeks to make investments that will change existing paradigms, such as D2C businesses like The Man Company, Super Daily, Burger Singh, as well as AI-assisted HR tech through Infeedo, to produce superior outcomes for society.
Accolades That Illuminates Excellence
Dheeraj’s journey as a business leader has been characterized by an unusual mixture of deep academic credentials along with quick execution methods. He has given guest lectures at the City University of London, as well as invited at the University of Michigan at Ross Business School. He has shared his thoughts on how technological disruptions can lead to fixing broken systems. When speaking about the future of Indian healthcare at the Harvard Business School in early 2025, Dheeraj provided a powerful representation of entrepreneurship and investment for his generation. He was awarded the Bharat Gaurav Award by the British Parliament and many other awards for his entrepreneurship; however, he has a philosophy of taking continuous action, which helps keep him grounded despite all the accolades he has received.
For Dheeraj, the chaos around him, including all of his startups, exits, and board meetings, has a richness of spiritual peace at the core. He attributes his energy and success to his unconditional devotion — a spiritual surrender — to Lord Krishna, which provides him with inner strength and peace when capital markets undergo turmoil. Dheeraj’s role is to be a responsible steward of resources by helping the next 50 startups to meet their innovation potential; for him, innovation must always serve a higher purpose.
A Pattern Impossible to Ignore
Although his journey spans diagnostics, fertility care, and consumer health, Dheeraj says that it wasn’t a single turning point that led him to build Crysta IVF and enter reproductive healthcare, but a pattern that became impossible to ignore. During his years in diagnostics at Redcliffe Labs, he had a front-row view of how people engage with healthcare, when they seek help, when they hesitate, and, more importantly, why they delay decisions that deeply impact their lives. With fertility, he noticed the delay was consistent. By the time couples walked in, they were already exhausted, not just medically, but emotionally and financially.
Redesigning the Experience of Parenthood
Much of this didn’t come from the complexity of treatment alone. It came from not knowing what to expect, confusion around costs, and navigating a deeply personal journey without clear guidance. That, to Dheeraj, is not just a medical problem, it’s a design problem. And design problems can be fixed. “That realization is what led him to build Crysta IVF, not just to deliver clinical excellence, but to redesign the entire experience so that couples feel informed, supported, and confident at every step of their journey toward parenthood.” Says Dr Neeta Jain, CEO and Co-founder, Crysta IVF.
Fixing the Core Gaps in Fertility Care
There were core gaps in fertility care that Dheeraj was determined to solve from day one. They were in the form of three things that were consistently broken. The first was clinical inconsistency. Outcomes varied too much across clinics, not because the doctors were different in talent, but because there were no standardized protocols holding the process together. What you got depended on where you went, and sometimes who was on shift. The second was financial opacity. Most couples had no honest picture of what the full journey would cost until they were already deep into it. That kind of uncertainty is hard to carry when you are already under stress. The third was the absence of structured support. IVF involves hope and grief in the same process, sometimes in the same week. Clinics were mostly equipped for the clinical part; the human part was largely left unaddressed.
Defining Excellence Through the Human Journey
He built Crysta IVF to treat all three as equally important, not as extras layered on top of care, but as the core of what care should mean. Excellence, for him, is not about numbers alone. It is about how a couple feels throughout the entire journey. The first part is clinical rigor. Results matter, but they should reflect every kind of patient who walks in, not just the easy cases. Behind every case is a couple that has waited and hoped quietly. Focusing only on straightforward journeys is not fair to the ones who need the team the most.
Clarity, Calm, and Outcome Orientation
The second part of his vision is process integrity. IVF can be overwhelming. Dheeraj believes couples deserve to know what lies ahead before they begin: the steps, the timelines, and what it may demand of them emotionally and financially. When there is clarity, there is calm, and that matters more than people often realize. Finally, there is outcome orientation. Success is not just a number. It is the moment a couple finally holds their child after everything they have been through. That is why he focuses on live birth rates and on how long it takes to reach the right treatment. Every delay is hope stretched further.
Extending Accessibility into Fertility Care
Dheeraj has always emphasized accessibility in healthcare through ventures like Redcliffe Labs. Today, he is extending that philosophy into fertility care, especially in Tier 2 and Tier 3 cities. In diagnostics, scale follows logistics and technology. Fertility care is more complex. He notes that you need trained embryologists, IVF-grade laboratories, and specialists experienced in complicated cases. That talent pipeline is thin outside the metros, and he views that as the real constraint.
The Hub and Spoke Model of Care
His approach is hub and spoke. A fully equipped clinical hub holds the laboratory, the specialist team, and advanced diagnostic capability. Satellite centers handle consultations, monitoring, and follow-up. A couple in a smaller city does not need to relocate for weeks. They come in for the parts that require the hub, and everything else happens closer to home. Alongside infrastructure, Dheeraj and his team invest in training, fellowship programs, and mentorship structures. Because for him, access without quality is not access; it is just presence. The goal is to make both available in the same place.
Redesigning the Patient Experience
IVF is both emotionally and financially demanding. That is why, at Crysta IVF, Dheeraj is redesigning the patient journey to make it more transparent, supportive, and outcome-driven. He and his team started by asking a different question: not “what happens inside the clinic?” but “what is the couple experiencing before they even walk in?” That shift changed everything. The anxiety does not begin at the consultation. It begins months earlier, when a couple first realizes something may be wrong and has no clear path forward. So, he tries to meet them there with clear information, no jargon, and no pressure.
Honesty, Clarity, and Emotional Stability
Dheeraj provides an honest picture of what the process looks like and what it will require medically, financially, and emotionally. Every patient gets a structured roadmap before treatment starts. Costs are discussed upfront, not in pieces. His care coordinators are there for support, not sales. When a patient has a question at 10 pm after a procedure, someone will answer. For someone in the middle of treatment, Dheeraj believes that is what stability feels like. He is building it by design, not as an exception.
The Four Shifts Defining the Future of Fertility
The fertility sector in India is rapidly evolving. Dheeraj believes four shifts are already becoming visible, and they will shape how fertility care evolves from here. The first is consolidation. A large part of the IVF landscape is still fragmented, and he notes that this creates inconsistency. Over time, more structured and protocol-driven setups will raise the baseline of care. The second is the growing acceptance of fertility preservation. Today, it is still limited to a smaller segment, but as awareness improves and costs become more manageable, he anticipates more individuals will start planning earlier rather than reacting later.
Integrating Diagnostics and Evolving Regulation
The third shift is the deeper integration of diagnostics. Dheeraj believes fertility treatment will become more informed from the start, with genetic and hormonal assessments guiding decisions instead of being added later. And finally, regulation will continue to evolve. Frameworks are in place, and as implementation becomes more consistent, he sees it bringing greater clarity and accountability across the sector. Together, these shifts move the space toward being more structured, predictable, and patient-focused.
Breaking Stigma Through Medical Legitimacy
Fertility awareness is still a sensitive topic in many parts of India, and Crysta IVF is contributing to breaking stigma and encouraging early intervention. Dheeraj observes that stigma in fertility is not one thing; in some households, it is cultural, where seeking outside help feels like an admission of something private, while in others, it is fear of judgment or simply not knowing what is normal. Couples wait years because no one has told them that waiting is not always the right approach. What he and his team try to do is quite simple: they treat fertility concerns as a legitimate medical matter, the same way anyone would treat a cardiac concern or a metabolic issue. When patients feel that, they come forward earlier, which almost always means better outcomes.
The Power of Immediate Impact and Innovation
Dheeraj guides couples toward an evaluation after twelve months of trying, or earlier when risk factors are present. He believes consistency builds trust, and trust is what makes someone pick up the phone. Personally, his passion for building healthcare solutions that combine impact, innovation, and scale is driven by a deep need to solve problems. He feels healthcare is unusual because the feedback loop between what is built and what it means for a person is immediate and real. When a process works properly, someone’s life moves forward in a way it could not before. That is not abstract to him; he sees it.
Closing the Gaps in Reproductive Care
What keeps Dheeraj going are two things sitting together. The first is how much is still broken; the gaps in reproductive care are large and life-shaping for many couples. The second is how much is now fixable through better diagnostic tools, stronger clinical knowledge, and improving infrastructure — all more available than five years ago. When those two things are true at the same time, he feels staying on the sideline is hard to justify. Technology in fertility is not a future conversation anymore; it is already shaping how decisions get made inside the clinic.
The Role of Genomics and AI in Precise Treatment
Take genomics, for example. For couples who have faced repeated failures, Dheeraj notes that Preimplantation Genetic Testing removes a layer of uncertainty that used to cost additional cycles and emotional weight. AI is doing something similar in embryo assessment, adding accuracy to human judgment that was difficult to standardize at scale. What he finds more interesting, though, is how AI is now able to map a patient’s biology to build a protocol specific to them. His underlying idea is straightforward: the more you understand before you begin, the fewer corrections you need to make along the way.
The Discovery That Redefined Patient Support
There is one thing Dheeraj discovered while building Crysta IVF that completely changed how he approaches patient care today. He and his team believed that giving couples clear information up front would carry them through the entire process. They provided a structured roadmap, transparent costs, and realistic timelines. They assumed that if people knew what to expect, anxiety would stay manageable throughout. However, he realized that when a follicle count comes back lower than projected or a fertilization result doesn’t match what was discussed, no pre-treatment briefing is enough. At that moment, what the couple needs is not more information; they need a specific person who knows their case, picks up the phone, and explains what it means and what to do next.
Rebuilding for Continuity and Human Connection
The care coordinator model was originally built around information delivery, but Dheeraj had to rebuild it around continuity. This means the same person stays with the same patient from consultation to outcome. He acknowledges that it costs more and is harder to scale cleanly, but that rebuild changed the patient experience more than any clinical upgrade the team has made. Getting it wrong first was what taught him that.
The Urgent Need for Standardized Outcome Reporting
If Dheeraj could change one thing about how the Indian fertility sector is regulated right now, it would be outcome reporting. He believes that is the single change that would restructure the entire sector. Right now, there is no standard definition of what a ‘success rate’ means in Indian IVF. One clinic counts a positive pregnancy test, another counts a clinical pregnancy at six weeks, and a third counts live births. He notes that the patient comparing these numbers has no way of knowing they are not comparing the same thing.
Prioritizing Patient Information Over Clinic Marketing
Additionally, Dheeraj points out that most clinics don’t disclose the patient profile behind their numbers. A center treating only young, healthy cases will show better statistics than one that accepts difficult cases or older patients. The result is that the metric every couple relies on when choosing a clinic is the one that tells them the least. He cites the UK’s HFEA as a model that solved this through mandatory, standardized reporting of live birth rates. He views it as a simple decision to prioritize patient information over clinic marketing. Until India has an equivalent, he believes informed choice in this market remains more difficult than it needs to be.
Solving the Crisis of Trust in Tier 2 and Tier 3 Cities
There are thousands of IVF clinics in India, yet there was a specific thought that made Dheeraj build Crysta IVF with a focus on Tier 2 and Tier 3 patients. He saw that most IVF clinics were built for cities that already had access. While metro-based clinics are a legitimate business, that was not the problem he wanted to solve. A patient from a Tier 2 or Tier 3 city had the same medical need but lacked a nearby clinic operating at a standard they could trust. Consequently, they either traveled at a significant cost or delayed treatment — and in fertility care, he emphasizes that delay is not neutral but has clinical consequences.
A Market with Demand and No Quality Supply
For Dheeraj, Tier 2 and Tier 3 India is not a charity play; it is an underserved market with real demand and almost no quality supply. He believes that gap is both a healthcare problem and a business opportunity, and he does not think those two things are in conflict. The question for him was never whether to go there, but how to do it without diluting the clinical standard. He is focused on the harder problem: ensuring the patient doesn’t have to relocate while ensuring the quality doesn’t drop. That is what he and his team are building consistently, city by city.
A Structural Goal for National Care Standards
Looking ahead, Dheeraj and his team have a long-term vision for Crysta IVF in terms of expansion, innovation, and impact on reproductive healthcare in India. The core goal is a network where the standard of care does not change based on which city you are in. He believes a couple in Patna should have access to the same clinical rigor, diagnostic capability, and quality of support as a couple in Mumbai. That is a structural goal, not an aspirational statement. It requires specific investments in talent, laboratory standards, and training.
Translating Clinical Evidence into Practice
On innovation, Dheeraj wants Crysta IVF to be a place where emerging clinical evidence is translated into practice quickly. This includes new stimulation protocols, advances in endometrial assessment, and expanded applications of genetic testing. He notes that the gap between what research shows and what actually happens in clinics is often larger than it should be.
The Metric of Time: Compressing the Journey to Parenthood
On impact, the metric that matters most to him is time. He asks: how long does it take from the moment a couple realizes they need help to the moment they are in the right hands, with a clear plan? Compressing that timeline — financially, geographically, and emotionally — is the most meaningful thing he believes the organization can do.